INTERNATIONAL PATENT: RONGCAN (SHANGHAI) BIOTECH CO., LTD, 荣灿生物医药技术（上海）有限公司 FILES APPLICATION FOR "GROWTH HORMONE FUSION PROTEIN, NUCLEIC ACID DRUG AND USE THEREOF"

GENEVA, March 31 -- RONGCAN (SHANGHAI) BIOTECH CO., LTD (No. 46, Lane 100, Banxia RoadPudong New Area, Shanghai 201318), 荣灿生物医药技术（上海）有限公司 (中国上海市浦东新区半夏路100弄46号) filed a patent application (PCT/CN2024/118945) for "GROWTH HORMONE FUSION PROTEIN, NUCLEIC ACID DRUG AND USE THEREOF" on Sep 14, 2024. With publication no. WO/2025/060968, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the ...